SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: kendall harmon who wrote (840)8/25/1999 9:05:00 AM
From: Carmine Cammarosano  Respond to of 1906
 
Shares of Biogen (BGEN: news, msgs) lost 1 3/16 to 77 1/2 and Amgen (AMGN: news, msgs) shed 1 7/8 to 79 in Instinet. Merrill Lynch downgraded both stocks' near-term ratings to "accumulate" from "buy," on recent price appreciation. Merrill also said fundamentals remain strong and intact.